LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
2.75
EUR
-0.04
EUR
-1.26 %
09:37:10
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 3.12 USD | -0.13 USD | -3.99 % |
|---|
| Vortag | 3.25 USD | Datum | 20.07.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Injective Staking ETP | CH1360612134 | 61.25% | |
| 21Shares Ondo ETP | CH1396389921 | 57.31% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 52.72% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 43.90% | |
| 21Shares Pendle ETP | CH1495416997 | 20.92% | |
| 21Shares Jupiter ETP | CH1480821383 | 14.86% | |
| 21Shares Uniswap ETP | CH1135202096 | 11.45% | |
| 21shares Gram Staking ETP | CH1297762812 | 9.93% | |
| 21Shares XDC Network ETP | CH1464217285 | -3.15% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | -7.75% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 184.69% | |
| 21shares Morpho ETP | CH1506167027 | 71.34% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 28.79% | |
| 21Shares Ondo ETP | CH1396389921 | 18.40% | |
| 21Shares Injective Staking ETP | CH1360612134 | 10.35% | |
| 21Shares Jupiter ETP | CH1480821383 | -1.25% | |
| 21shares Gram Staking ETP | CH1297762812 | -4.41% | |
| 21Shares Bittensor ETP | CH1495416971 | -17.57% | |
| 21Shares Pendle ETP | CH1495416997 | -21.12% | |
| 21Shares XDC Network ETP | CH1464217285 | -28.01% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Bitcoin Gold ETP | CH1146882308 | -3.50% | |
| 21Shares Binance BNB ETP | CH0496454155 | -28.02% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -35.71% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | -43.89% | |
| 21Shares Bitcoin ETP | CH0454664001 | -44.65% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -52.89% | |
| 21Shares Injective Staking ETP | CH1360612134 | -66.84% | |
| 21Shares XDC Network ETP | CH1464217285 | -70.94% | |
| 21Shares Dogecoin ETP | CH1431521033 | -74.35% | |
| 21Shares Sui Staking ETP | CH1360612159 | -81.18% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 92.86% | |
| 21Shares Stellar ETP | CH1109575535 | 77.99% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 48.43% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 13.70% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 1.25% | |
| 21Shares Sui Staking ETP | CH1360612159 | -10.43% | |
| 21Shares Injective Staking ETP | CH1360612134 | -81.29% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 911’116.72 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 22.07.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 56.88 | |
| Performance 2 Jahre | 54.73 | |
| Performance 3 Jahre | 5.41 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |
ETP Kategorievergleich
| Name | 1J Perf. | |
|---|---|---|
| Aescap Life Sciences Investors Fonds | 57.16 | |
| ARK Genomic Revolution UCITS ETF Class A USD Accumulation | 57.26 | |
| BB Biotech AG Fonds | 57.90 | |
| RIM Global Bioscience EUR Fonds | 58.00 | |
| RIM Global Bioscience USD Fonds | 58.07 |